Últimas noticias sobre Ocean Biomedical (NASDAQ:OCEA) Bolsa

Ocean Biomedical

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACLS

AMKR

BHAT

BNAI

FLNC

GNPX

HLIT

LIXT

LSCC

NLSP

OCEA

PRLD

SGRY

SLQT

SLXN

TANH

VSTE

Lattice Semiconductor sorprende con un alza del 14,7% en el premercado. Descubre qué otras acciones están en movimiento.

Acciones de Lattice Semiconductor (LSCC) suben un 15%; 20 acciones que se mueven en el premercado

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

Ocean Biomedical Inc

Ocean Protocol - United States Dollar

Ocean Park High Income ETF

Ocean Park International ETF

Ocean Power Technologies, Inc. Common Stock

Ocean Power Technologies Inc

OCEAN SPRAY 4 PR by Ocean Spray Cranberries, Inc.

Ocean Spray Cranberries Inc

OCEAN THERMAL ENERGY CORP by Ocean Thermal Energy Corp.

Ocean Thermal Energy Corp

OceanFirst Financial Corp. - Common Stock

OceanFirst Financial Corp

OceanFirst Financial Corp. - Depositary Shares

OceanPal Inc

OceanTech Acquisitions I Corp

OceanTech Acquisitions I Corp Units (1 Ord Class A & 1 War)

OceanTech Acquisitions I Corp Warrants (12/05/2026)

OceanTech Acquisitions I Corp Class A

Oceana Group Ltd

OceanaGold Corp

OCEANAGOLD (PHILIPPINES) by OCEANAGOLD (PHILIPPINES) INC.

OceanaGold Philippines Inc

Oceaneering International, Inc. Common Stock

Oceaneering International Inc

OCEANIA HEALTHCARE LTD by Oceania Healthcare Ltd.

Oceania Healthcare Ltd

OCEANIC IRON ORE CORP NEW by Oceanic Iron Ore Corp.

Oceanic Iron Ore Corp

OCEANIC WIND ENERGY INC. by Oceanic Wind Energy Inc.

Oceanic Wind Energy Inc

OCEANSIX FUTURE PATHS LTD by OCEANSIX FUTURE PATHS LTD.

Oceansix Future Paths Ltd

WIIM

Palatin Technologies shares are trading higher after the company reported positive data from its Phase 2b diabetic kidney study.

Ocean Power Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NYSE">OPTT</a>) ("OPT" or the "Company"), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced the signing of a reseller agreement with Grava Hydrographic Solutions LLC ("Grava Hydro"), a U.S.-based specialist in hydrographic and oceanographic equipment integration and services.
Under the agreement, Grava Hydro will expand the availability, sales, and support of OPT's Unmanned Surface Vehicles (USVs), the Wave Adaptive Modular Vessels (WAM-V&#xAE;), throughout the United States.

OPTT

Ocean Power Technologies Signs Reseller Agreement With Grava Hydrographic Solutions To Expand U.S. Sales And Support Of Its Wave Adaptive Modular Vessels Unmanned Surface Vehicles

UBS analyst Joseph Spak downgrades BorgWarner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) from Buy to Neutral and lowers the price target from $38 to $31.

Downgrades

Price Target

Analyst Ratings

UBS Downgrades BorgWarner to Neutral, Lowers Price Target to $31

ELAB

PMGC Holdings shares are trading higher after the company's subsidiary entered a development and license agreement with Yuva Biosciences to discover and develop new pharmaceutical treatments for obesity, type 2 diabetes, and other cardiometabolic conditions.

UBS analyst Joseph Spak downgrades Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) from Buy to Neutral and lowers the price target from $91 to $58.

APTV

UBS Downgrades Aptiv to Neutral, Lowers Price Target to $58

Price pressures eased more than expected in March, offering significant relief to concerns over the front-loading effects of trade tariffs and further fueling investor risk-on sentiment following President Donald Trump&#8216;s surprising 90-day <a href="https://www.benzinga.com/markets/forex/25/04/44730411/asia-and-europe-markets-rally-after-trumps-tariff-u-turn-gold-nears-record-high-global-markets-today-while-us-slept">tariff pause on Wednesday. </a>
The annual inflation rate fell to 2.4% in March, the lowest level in six months, down from 2.8% in February, according to data released Thursday by the Bureau of Labor Statistics.
The figure was below economist expectations of 2.6%. On a monthly basis, the Consumer Price Index contracted by 0.1%, slowing from the 0.2% increase seen the previous month and below expectations of a 0.1% increase.
It marks the lowest monthly inflation reading since May 2020.
A 6.3% drop in gasoline prices was more than offset by increases in electricity and natural gas indexes. In contrast, the food index rose 0.4% in March, driven by a 0.5% increase in food at home and a 0.4% rise in food away from home.
Shelter costs, which make up nearly a third of the consumer basket, edged up just 0.2%—the smallest monthly increase since August 2021.
Core inflation, which excludes volatile food and energy prices, was up 2.8% year-over-year, the lowest since March 2021.
The outcome was lower than the expected 3% and down from 3.1% in February. Month-over-month, core inflation increased by 0.1%, declining from February's 0.2% pace and below estimates of 0.3%.
Ahead of the March inflation report, traders had priced in a 16% probability of a 25-basis-point rate cut by the Federal Reserve at its upcoming May 7 meeting. By June, markets had factored in a 75% chance of a rate cut.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Measure</th>
<th>March 2025</th>
<th>Consensus</th>
<th>February 2025</th>
</tr>
</thead>
<tbody>
<tr>
<td>Inflation Rate MoM</td>
<td>-0.1% (Lowest since May 2020)</td>
<td>0.1%</td>
<td>0.2%</td>
</tr>
<tr>
<td>Inflation Rate YoY</td>
<td>2.4% (Lowest since September 2024)</td>
<td>2.6%</td>
<td>2.8%</td>
</tr>
<tr>
<td>Core Inflation Rate MoM</td>
<td>0.1% (Lowest since June 2024)</td>
<td>0.3%</td>
<td>0.2%</td>
</tr>
<tr>
<td>Core Inflation Rate YoY</td>
<td>2.8% (Lowest since March 2021)</td>
<td>3%</td>
<td>3.1%</td>
</tr>
</tbody>
</table>
</figure>
<h2 class="wp-block-heading">Market Reactions</h2>
S&amp;P 500 futures were down 1.6% as of 8:35 a.m. in New York, paring steeper overnight losses following the benign inflation report.
On Wednesday, the index – as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – closed 10.5% higher, notching the strongest one-day gain since 2008. 
Futures on the Nasdaq 100 were 1.7% lower. A day earlier, tech stocks – tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) – rocketed 12%, the largest jump since October 2008. Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) – the world&#8217;s largest company by market capitalization – were down 3.5% during the premarket trading Thursday after closing 15% higher a day earlier, setting their best day since January 1998. 
Yields on 2-year Treasury notes – which are more sensitive to interest rate expectations – fell by nearly 10 basis points. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44723376/goldman-sachs-scraps-recession-call-after-trumps-surprise-tariff-pause-as-wall-street-marks-strongest-day-since-2008">Goldman Sachs Scraps Recession Call After Trump&#8217;s Surprise Tariff Pause As Wall Street Marks Strongest Day Since 2008</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Bonds

Broad U.S. Equity ETFs

Econ #s

Federal Reserve

Tech

ETFs

AAPL

March Inflation Rate Cools Far More Than Expected, Raises Hopes For Near-Term Fed Rate Cuts

Stephens &amp; Co. analyst Jeff Garro reiterates TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) with a Equal-Weight and maintains $28 price target.

Reiteration

TBRG

Stephens & Co. Reiterates Equal-Weight on TruBridge, Maintains $28 Price Target

Contracts

OPTX

Syntec Optics Holdings Secures $2.1M Follow-On Critical Optics Orders For Next Generation U.S. Defense Integrated Scopes

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B of A Securities analyst Christopher Nardone upgraded the rating for Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) from Neutral to Buy and raised the price target from $17 to $20. Levi Strauss shares closed at $14.93 on Wednesday. <a href="https://www.benzinga.com/quote/levi/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Mark Delaney upgraded Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) from Neutral to Buy and lowered the price target from $31 to $27. Sensata shares closed at $20.88 on Wednesday. <a href="https://www.benzinga.com/quote/st/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer analyst Martin Yang upgraded the rating for Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) from Perform to Outperform and maintained the price target of $70. Roblox shares closed at $57.31 on Wednesday. <a href="https://www.benzinga.com/quote/rblx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Luke Sergott upgraded Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) from Equal-Weight to Overweight and lowered the price target from $240 to $205. Danaher shares closed at $191.89 on Wednesday. <a href="https://www.benzinga.com/quote/dhr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst Mark Miller upgraded the rating for Western Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) from Hold to Buy and announced a $55 price target. Western Digital shares closed at $36.30 on Wednesday.  <a href="https://www.benzinga.com/quote/wdc/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying WDC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="612" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-1024x612.png" alt="" class="wp-image-865891" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-1024x612.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10084525/image-66.png 1073w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a> </li>
</ul>
Photo via Shutterstock

Upgrades

LEVI

RBLX

This Western Digital Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

AMZN

Amazon CEO Jassy Says Seeing Significant Growth On Discretionary Items, Not Seeing Meaningful Impact From All The Noise Around Tariffs

LOVE

Lovesac shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 and FY26 guidance with its midpoints above estimates.

Guidance

Amazon CEO Andy Jassy Says I Do Think That It's Possible This Environment Will Be A Little Bit Easier To To Start To Acquire

Truist Securities analyst Youssef Squali maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Buy and lowers the price target from $53 to $36.

Truist Securities Maintains Buy on Wayfair, Lowers Price Target to $36

LUCD

Lucid Dagnositcs shares are trading lower following a public offering of 12.5 million shares of common stock priced at $1.20 per share.

Truist Securities analyst Anthony Hau maintains Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) with a Buy and lowers the price target from $142 to $135.

Truist Securities Maintains Buy on Sun Communities, Lowers Price Target to $135

Amazon CEO Andy Jassy On Tariffs, Says: Too Early To See Change In Consumer Behavior; Says We're Going To Do Everything We Can To Keep Prices As Low As Are You Seeing; We Have Done Some Strategic Forward Inventory Buys

Truist Securities analyst Jailendra Singh maintains Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) with a Hold and lowers the price target from $347 to $333.

MEDP

Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $333

MRIN

Marin Software shares are trading lower after the company announced plans for dissolution, which its board of directors has approved.

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Buy and lowers the price target from $263 to $216.

Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $216

Truist Securities analyst Jailendra Singh maintains Icon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) with a Buy and lowers the price target from $262 to $208.

ICLR

Truist Securities Maintains Buy on Icon, Lowers Price Target to $208

Press Releases

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company's Malaria Treatment and Prevention Platforms

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors.

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, DGLY, LYT, SIGL, Amid FBI Warnings, Signal App Breach, and Data Privacy Crisis"

Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR): Cybersecurity Platform Redefines Privacy

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

Comments

Ocean Biomedical

Noticias

Últimas noticias sobre Ocean Biomedical (NASDAQ:OCEA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL